Cargando…
HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity
BACKGROUND: G protein-coupled receptors (GPCRs) are the targets of a large number of drugs currently in therapeutic use. Likewise, the glutamate ionotropic N-methyl-D-aspartate receptor (NMDAR) has been implicated in certain neurological disorders, such as neurodegeration, neuropathic pain and mood...
Autores principales: | Vicente-Sánchez, Ana, Sánchez-Blázquez, Pilar, Rodríguez-Muñoz, María, Garzón, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851374/ https://www.ncbi.nlm.nih.gov/pubmed/24093505 http://dx.doi.org/10.1186/1756-6606-6-42 |
Ejemplares similares
-
The σ1 Receptor and the HINT1 Protein Control α2δ1 Binding to Glutamate NMDA Receptors: Implications in Neuropathic Pain
por: Rodríguez-Muñoz, María, et al.
Publicado: (2021) -
The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia
por: Sánchez-Blázquez, Pilar, et al.
Publicado: (2014) -
The σ1 Receptor Engages the Redox-Regulated HINT1 Protein to Bring Opioid Analgesia Under NMDA Receptor Negative Control
por: Rodríguez-Muñoz, María, et al.
Publicado: (2015) -
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction
por: Rodríguez-Muñoz, María, et al.
Publicado: (2016) -
Calmodulin Supports TRPA1 Channel Association with Opioid Receptors and Glutamate NMDA Receptors in the Nervous Tissue
por: Cortés-Montero, Elsa, et al.
Publicado: (2020)